The immune system is supposed to keep us healthy, but in Parkinson’s it may be too much of a good thing. MJFF Contributing Editor Dave Iverson moderates a conversation with MJFF CEO Todd Sherer, PhD, and Jeff Bronstein, MD, PhD, director of the Movement Disorders Program at the University of California, Los Angeles where they discuss:
The overall function of the immune system
How the immune system and inflammation may play a role in Parkinson’s disease
How scientists are using immune system properties to develop therapies against the disease
Pesticide exposure and head injury – risk factors for Parkinson’s – linked to inflammation
People with PD show inflammation in brain tissue
Imbalance in gut bacteria (microbiome) in PD may impact immune response
People with inflammatory bowel disease and hepatitis C at greater risk of PD
People who took anti-inflammatory drugs for other conditions at lower risk of PD
Research funded by Shake It Up Australia Foundation and the Michael J. Fox Foundation has uncovered a promising new therapy for Parkinson’s to reduce inflammation. Read more about this study